Tinospora cordifolia as an adjuvant drug in the treatment of hyper-reactive malarious splenomegaly - Case reports

Journal of Vector Borne Diseases

Volumn 42, Issue 1, 2005, Pages 36-38

  Singh, Ranjan Kumar ^a,b  

^a District Hospital   (India)

^b Near Vishal Bajrangbali Mandir   (India)

Author keywords

Antimalaria activity; Hyper reactive malarious splenomegaly; Immunomodulator; Tinospora cordifolia

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HEMOGLOBIN; IMMUMOD; IMMUNOGLOBULIN M; IMMUNOMODULATING AGENT; TINOSPORA CORDIFOLIA EXTRACT;

ADJUVANT THERAPY; ADULT; ARTICLE; CASE REPORT; CHEMOPROPHYLAXIS; DRUG SAFETY; ENDEMIC DISEASE; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOMODULATION; INDIA; LIVER FUNCTION TEST; MALARIA; MALE; PLASMODIUM VIVAX; PROGNOSIS; RATING SCALE; SPLEEN SIZE; SPLENOMEGALY; TINOSPORA; TREATMENT OUTCOME; WELLBEING;

ADULT; CHEMOTHERAPY, ADJUVANT; CHLOROQUINE; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBINS; HUMANS; IMMUNOGLOBULIN M; MALARIA, VIVAX; MALE; MEDICINE, AYURVEDIC; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; SPLEEN; SPLENOMEGALY; TINOSPORA;

EID: 21244498126     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Singh SS, Pandey SC, Shrivastava S, Gupta VS, Palio B. Chemistry and medicinal properties of Tinospora cordifolia. Indian J Pharmacol 2003; 35: 83-9.
2. Najib Nik A, Rahman N, Furuta T, Kojima S, Takane K, Ali Mohd M. Antimalarial activity of extracts of Malaysian medicinal plants. J Ethnopharmacol 1999; 649(3): 249-54.
3. Maneti F, Porta E, Epsposito R. Treatment of hyper-reactive malarious splenomegaly syndrome. Lancet 1994; 343 (8910): 1441-2.
4. Hoffman SL, Piessens WF, Ratiwayanto S, Hussein PR, Kurniawan L, Piessens PW, Campbell TR, Marwoto HA. Reduction of suppressor T-lymphocytes in tropical spleno-megaly syndrome. New Eng J Med 1994; 310: 337-41.
5. Jones IG, Lowenthal MN. Fulminant tropical splenomegaly syndrome. Med J Aust 1975; 2(16): 645-7.
6. Bates I, Bedu-Add G. Review of diagnostic criteria of hyper-reactive malarious splenomegaly. Lancet 1997: 349(9059): 1178.
7. Schag CC, Heinrich RL, Ganj PA. Karnofsky performance status revised: reliability, validity and guidelines. J Clin Oncol 1984; 2: 187-93.
8. Bates I, Bedu-Add G, Bevan DH, Rutherford TR. Use of lg gene rearrangements in hyper-reactive malarious splenomegaly syndrome. Lancet 1991; 337(8740): 505-7.
9. Torres JR, Villegas L, Perez H, Suarez L, Torres VMA. Campos M. Low grade parasitaemia and cold agglutinins in patients with hyper-reactive malarious splenomegaly and acute haemolysis. Ann Trop Med Parasitol 2003; 97(2): 125-30.